Jain Nikunj has filed 6 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 225000 shares of SANGAMO THERAPEUTICS, INC ($SGMO) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Jain Nikunj | Principal Accounting Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 336,494,489 | 9999.99% | 0.07% |
| Feb. 24, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Jain Nikunj | Principal Accounting Officer | F | Common Stock | 666 | $0.47 | 242,330.0000 | 336,494,489 | 0.27% | 0.00% |
| Feb. 25, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Jain Nikunj | Principal Accounting Officer | F | Common Stock | 5119 | $0.47 | 237,211.0000 | 336,494,489 | 2.11% | 0.00% |
| Jan. 22, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Jain Nikunj | Principal Accounting Officer | F | Common Stock | 7721 | $0.40 | 242,996.0000 | 336,494,489 | 3.08% | 0.00% |
| Nov. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Jain Nikunj | Principal Accounting Officer | F | Common Stock | 578 | $0.42 | 245,717.0000 | 336,494,489 | 0.23% | 0.00% |
| Oct. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Jain Nikunj | Principal Accounting Officer | F | Common Stock | 6708 | $0.66 | 246,295.0000 | 224,710,019 | 2.65% | 0.00% |